Bristol-Myers Squibb Company
BMY
#165
Rank
$138.026 B
Marketcap
United States
Country
$67.57
Share price
6.23%
Change (1 day)
39.47%
Change (1 year)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis…
Key Metrics
Trailing P/E
14.01
Forward P/E
9.69
EPS (TTM)
$4.54
Forward EPS
$6.56
Price / Book
5.82
EV / EBITDA
8.7x
Beta
0.23
Dividend Yield
3.96%
Return on Equity
46.60%
Return on Assets
10.72%
Debt / Equity
201.86
Current Ratio
1.53
Gross Margin
71.66%
Operating Margin
34.42%
Net Profit Margin
18.87%
Free Cash Flow
$8.114B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 16
-3.71%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$48.195B
Latest Net Income$7.054B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Bristol-Myers Squibb Company with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
BMY
No recent news available. Set FINNHUB_API_KEY to enable news.
